公司资料
Charles River 股价、新闻与催化剂
- 股票代码:
- CRL
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
286.64 USD (+2.35%)
收盘价
最后更新: 2026年8月17日
8.42B USD
市值
股价为何变动
As of Aug 17, 2026, CRL closed up 2.35% at $286.64. No new same-company headline was identified in the current news window.
公司概览
Preclinical Research Services
Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development.
Research Models and Services
The company supplies research models and related services used in basic research, target validation and preclinical studies. It also provides safety-assessment and discovery services.
Manufacturing Solutions
Charles River supports biologic testing, microbial solutions and other quality-control activities used in pharmaceutical manufacturing. Following divestitures, the company is refocusing on its core research and preclinical portfolio.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。